Al-Maidan Clinic for Oral Health Services Co. (K.S.C.C)

As of June 30, 2026, Al-Maidan Clinic for Oral Health Services Co. (K.S.C.C) carries a market capitalization of 189.54B, placing it among publicly traded companies globally. Its enterprise value stands at 139.96B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Al-Maidan Clinic for Oral Health Services Co. (K.S.C.C) has 202.50M shares outstanding.

As of June 30, 2026, Al-Maidan Clinic for Oral Health Services Co. (K.S.C.C) trades at a trailing price-to-earnings ratio of 17.80. The price-to-sales ratio is 2.99, and the price-to-book ratio stands at 1.97.

As of June 30, 2026, Al-Maidan Clinic for Oral Health Services Co. (K.S.C.C) trades at an EV/EBITDA multiple of 12.57 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 2.21 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 17.15 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. Al-Maidan Clinic for Oral Health Services Co. (K.S.C.C) trades at an EV/FCF ratio of 19.92, comparing the total takeover cost of the business to the cash it actually generates for all capital providers. These enterprise value multiples are built on an enterprise value of 139.96B versus a market cap of 189.54B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Al-Maidan Clinic for Oral Health Services Co. (K.S.C.C) maintains a current ratio of 2.72, meaning it holds 2.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 1.52, indicating elevated leverage, while an interest coverage ratio of 58.87 demonstrates strong ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Al-Maidan Clinic for Oral Health Services Co. (K.S.C.C) posted a return on equity (ROE) of 11.44, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 8.02 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 7.86, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 11.17, useful for judging operating efficiency across full business cycles. Inventory turnover of 13.83 indicates how many times Al-Maidan Clinic for Oral Health Services Co. (K.S.C.C) sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Al-Maidan Clinic for Oral Health Services Co. (K.S.C.C) recorded 550.97M in income tax expense. That works out to an effective tax rate of 4.90, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 11.24B, leaving 10.65B in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 18, 2026, Al-Maidan Clinic for Oral Health Services Co. (K.S.C.C)'s stock has declined approximately 6.78% over the past 52 weeks. The 50-day moving average sits at 956.78, while the 200-day moving average is 838.41.

Over the twelve months ended June 30, 2026, Al-Maidan Clinic for Oral Health Services Co. (K.S.C.C) generated 63.39B in revenue and converted that into 10.65B in net income, yielding earnings per share of 52.79. EBITDA reached 11.13B, while operating income came in at 7.94B.

As of June 30, 2026, Al-Maidan Clinic for Oral Health Services Co. (K.S.C.C) holds 51.16B in cash and equivalents against 1.46B in total debt, resulting in a net debt position of -29.35B. Total book value stands at 96.23B, with working capital of 56.17B providing operational flexibility.

Al-Maidan Clinic for Oral Health Services Co. (K.S.C.C) produced 12.98B in operating cash flow over the twelve months ended June 30, 2026. After subtracting -6.13B in capital expenditures, free cash flow totaled 6.84B - equivalent to 33.80 per share.

Over the twelve months ended June 30, 2026, Al-Maidan Clinic for Oral Health Services Co. (K.S.C.C) posted a gross margin of 30.04, reflecting its pricing power and cost economics. The operating margin of 12.52 and net profit margin of 16.80 provide insight into operational efficiency.

Over the twelve months ended June 30, 2026, Al-Maidan Clinic for Oral Health Services Co. (K.S.C.C) paid dividends of 14.97 per share. The dividend payout ratio of 28.32 indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield stands at 3.61, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 1.96, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Al-Maidan Clinic for Oral Health Services Co. (K.S.C.C) shareholders.

Al-Maidan Clinic for Oral Health Services Co. (K.S.C.C)'s most recent stock split took place on September 4, 2023 with a 10:9 split ratio.

As of June 30, 2026, Al-Maidan Clinic for Oral Health Services Co. (K.S.C.C) has an Altman Z-Score of 4.89, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.